New IV iron shot aims to boost low blood counts in kids who can't take pills

This study tests an intravenous iron medicine (ferric derisomaltose) in 200 children aged 0 to 18 who have iron deficiency anemia due to chronic kidney disease or who cannot take or do not respond to oral iron. The goal is to see if one or two doses can raise hemoglobin levels safely. The trial lasts about 10 weeks and involves 6 to 9 clinic visits.